Published in Neuropsychopharmacology on January 01, 2010
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. Curr Neuropharmacol (2015) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med (2005) 4.64
The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol (2004) 3.29
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry (2007) 3.22
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology (2006) 2.47
Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev (2008) 2.30
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol (2000) 2.11
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine (1992) 1.97
Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol (2001) 1.74
Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock (2007) 1.59
Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res (2006) 1.48
Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms. Arch Gen Psychiatry (1995) 1.46
Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res (2008) 1.46
Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res (1996) 1.43
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res (1999) 1.33
Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res (2006) 1.25
Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis (2008) 1.13
Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology (2005) 1.13
Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.09
Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert Rev Neurother (2006) 1.02
Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Res (1997) 0.99
Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci (1996) 0.98
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur Neuropsychopharmacol (2000) 0.98
Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol (1996) 0.96
The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl (2007) 0.96
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. Eur Arch Psychiatry Clin Neurosci (2004) 0.95
Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand (1994) 0.93
COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des (2008) 0.93
In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res (1997) 0.91
Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.90
Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment. Mol Psychiatry (2000) 0.90
Celecoxib augmentation of continuously ill patients with schizophrenia. Biol Psychiatry (2005) 0.90
Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand (1994) 0.90
Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia. Eur Arch Psychiatry Clin Neurosci (1997) 0.89
Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology (1998) 0.88
Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist. J Neurosci Res (2007) 0.88
Effect of risperidone on serum cytokines. Int J Neurosci (2001) 0.86
Cytokine production in unmedicated and treated schizophrenic patients. Neuroreport (2000) 0.83
Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry (1997) 0.82
An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (1997) 0.81
Cytokine profiles in drug-naive schizophrenic patients. Schizophr Res (2001) 0.81
Decreased production of interleukin-2 in schizophrenia. Ann N Y Acad Sci (1987) 0.81
Cytokine production in drug-free and neuroleptic-treated schizophrenic patients. Biol Psychiatry (1995) 0.81
Decreased interleukin-2 production in schizophrenic patients. Biol Psychiatry (1989) 0.81
Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur Arch Psychiatry Clin Neurosci (1993) 0.80
Decreased interleukin-2 production in Korean schizophrenic patients. Biol Psychiatry (1998) 0.80
Haloperidol and soluble interleukin-2 receptors. Biol Psychiatry (1991) 0.79
Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res (1995) 0.79
Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patients. Biol Psychiatry (1994) 0.79
Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch Gen Psychiatry (1989) 0.79
The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness. Biol Psychiatry (1991) 0.76
Neuroendocrine aspects of primary endogenous depression. X: Serum growth hormone measures in patients and matched control subjects. Biol Psychiatry (1990) 0.76
Robotic compared with laparoscopic sacrocolpopexy: a randomized controlled trial. Obstet Gynecol (2014) 1.66
Persistent sexual dysfunction impairs quality of life after cardiac transplantation. J Sex Med (2010) 1.38
Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol (2012) 1.05
Antibodies to thyroid peroxidase arise spontaneously with age in NOD.H-2h4 mice and appear after thyroglobulin antibodies. Endocrinology (2010) 1.04
Murine model of Hirschsprung-associated enterocolitis. I: phenotypic characterization with development of a histopathologic grading system. J Pediatr Surg (2010) 1.04
Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors. Hum Pathol (2011) 0.98
Murine model of Hirschsprung-associated enterocolitis II: Surgical correction of aganglionosis does not eliminate enterocolitis. J Pediatr Surg (2010) 0.97
A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Qual Life Res (2012) 0.93
Exploring potential use of internet, E-mail, and instant text messaging to promote breast health and mammogram use among immigrant Hispanic women in Los Angeles County. Am Surg (2013) 0.92
Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patient. HPB (Oxford) (2011) 0.90
Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Am J Obstet Gynecol (2013) 0.89
Perceived impact of the disclosure of a schizophrenia diagnosis. Community Ment Health J (2010) 0.87
Splenic lymphopenia in the endothelin receptor B-null mouse: implications for Hirschsprung associated enterocolitis. Pediatr Surg Int (2011) 0.87
A preliminary study of the effects of repeated massage on hypothalamic-pituitary-adrenal and immune function in healthy individuals: a study of mechanisms of action and dosage. J Altern Complement Med (2012) 0.86
Early recognition of risk factors for adverse outcomes during hospitalization among Medicare patients: a prospective cohort study. BMC Geriatr (2013) 0.85
FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease. Clin Nucl Med (2012) 0.82
Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma. Thyroid (2013) 0.81
Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study. Bipolar Disord (2012) 0.80
Early use of low residue diet is superior to clear liquid diet after elective colorectal surgery: a randomized controlled trial. Ann Surg (2014) 0.79
The Integrated Web Portal for Escalation with Overdose Control (EWOC). Open Med Inform J (2013) 0.79
Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer. Thyroid (2015) 0.77
Paget's disease of the nipple with parenchymal ductal carcinoma in situ is associated with worse prognosis than Paget's disease alone. Am Surg (2013) 0.77
MyD88 and TRIF mediate the cyclic adenosine monophosphate (cAMP) induced corticotropin releasing hormone (CRH) expression in JEG3 choriocarcinoma cell line. Reprod Biol Endocrinol (2009) 0.75
One-Year Outcomes After Minimally Invasive Sacrocolpopexy. Female Pelvic Med Reconstr Surg (2016) 0.75
Surgical flow disruptions during robotic-assisted radical prostatectomy. Can J Urol (2017) 0.75
LYMPHOCYTIC THYROIDITIS IS ASSOCIATED WITH INCREASED NUMBER OF BENIGN CERVICAL NODES AND FEWER CENTRAL NECK COMPARTMENT METASTATIC LYMPH NODES IN PATIENTS WITH DIFFERENTIATED THYROID CANCER. Endocr Pract (2016) 0.75
Discordance between pathologic and radiologic tumor size on breast MRI may contribute to increased re-excision rates. Am Surg (2011) 0.75